Ilumetri – Tildrakizumab uses, dose and side effects
Ilumetri contains the active substance tildrakizumab. Tildrakizumab belongs to a group of medicines called interleukin inhibitors (IL inhibitors).
Read MoreIlumetri contains the active substance tildrakizumab. Tildrakizumab belongs to a group of medicines called interleukin inhibitors (IL inhibitors).
Read More© 2022 Medicore. All Rights Reserved.Weblizar